February 07, 2022 11:43 am
Dr. Reddy's announced Monday DCGI has granted approval to the Sputnik Light vaccine, developed by Russia’s Gamaleya Center, for restricted emergency use.
January 21, 2022 9:39 am
The study was an independent comparative one conducted at the National Institute for Infectious Diseases Lazzaro Spallanzani (Italy) by a joint team of researchers of the Institute and the Gamaleya Center.
December 06, 2021 7:46 am
The Russian leader also argued that WHO's approval should open the door for Russians and others who have had the Sputnik V vaccine to travel more freely around the world.
October 13, 2021 10:27 pm
Russian Health Minister Mikhail Murashko earlier this month said that all barriers to register the vaccine with the WHO had been cleared and only some paperwork remained to be completed.
August 14, 2021 2:04 pm
Most hospital authorities said a steady response is expected for the second dose of Covishield as well.
July 27, 2021 11:30 am
Human trials of a COVID-19 vaccine combining the AstraZeneca/Oxford shot with Sputnik V had already been approved in Azerbaijan, the United Arab Emirates, Belarus and Argentina.
July 14, 2021 1:17 pm
A new study examined whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly.
July 14, 2021 7:25 am
Russia's Sputnik V vaccine, developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, was granted emergency use authorisation in India in May.
July 11, 2021 11:12 am
According to officials, 15,54,026 people have received at least one dose of a vaccine in Gurgaon so far.
July 09, 2021 5:00 pm
Demand for vaccination had been tepid, but authorities say it has now picked up significantly. Adding to concerns about Russian vaccines, Sputnik V in particular, was a lack of recognition by some Western nations.